RGNX logo

REGENXBIO (RGNX) Selling, General & Administrative Expenses

Annual SGA

$88.49 M
+$3.21 M+3.77%

December 31, 2023

Summary

Performance

1-Year Change

+3.77%

3-Year Change

+38.67%

5-Year Change

+140.15%

15-Year Change

+225%

RGNX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.96%
RGNX annual SGA is higher than 69.96% of companies in Healthcare sector

High & Low

All-time High

$88.49 M
RGNX annual SGA is currently at an all-time high

3-Year Low

$79.33 M
RGNX annual SGA is currently +11.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RGNX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
RGNX next annual earnings announcement is scheduled for Mar 13, 2025

OtherRGNXexpensesmetrics:

Annual Total Expenses

$358.37 M
RGNX annual total expenses is $358.37 million

Annual Operating Expenses

$321.16 M
RGNX annual total operating expenses is $321.16 million

Annual Cost Of Goods Sold

$37.21 M
RGNX annual cost of goods sold is $37.21 million

Annual Interest Expense

$6.86 M
RGNX annual interest expense is $6.86 million

Quarterly SGA

$19.42 M
+$567.00 K+3.01%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-7.65%

5-Year Change

+56.6%

RGNX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.98%
RGNX quarterly SGA is higher than 66.98% of companies in Healthcare sector

High & Low

All-time High

$23.70 M
RGNX quarterly SGA is currently -18.04% below its historical high of $23.70 million

3-Year Low

$18.29 M
RGNX quarterly SGA is currently +6.18% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
RGNX next earnings announcement is scheduled for Mar 13, 2025

OtherRGNXexpensesmetrics:

Quarterly Total Expenses

$86.28 M
RGNX quarterly total expenses is $86.28 million

Quarterly Operating Expenses

$73.89 M
RGNX quarterly total operating expenses is $73.89 million

Quarterly Cost Of Goods Sold

$12.39 M
RGNX quarterly cost of goods sold is $12.39 million

Quarterly Interest Expense

$820.00 K
RGNX quarterly interest expense is $820.00 thousand

TTM SGA

-$3.18 B
-$238.81 M-8.13%

September 30, 2024

Summary

Performance

3-Month Change

-4298.12%

1-Year Change

-4298.12%

3-Year Change

-4342.03%

5-Year Change

-6229.02%

RGNX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.26%
RGNX TTM SGA is higher than 14.26% of companies in Healthcare sector

High & Low

All-time High

-$28.81 M

3-Year Low

-$3.18 B
RGNX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
RGNX next earnings announcement is scheduled for Mar 13, 2025

OtherRGNXexpensesmetrics:

Annual Total Expenses

$358.37 M
RGNX annual total expenses is $358.37 million

Annual Operating Expenses

$321.16 M
RGNX annual total operating expenses is $321.16 million

TTM Cost Of Goods Sold

$38.49 M
RGNX TTM cost of goods sold is $38.49 million

TTM Interest Expense

$4.61 M
RGNX TTM interest expense is $4.61 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$88.49 M
RGNX annual SGA is $88.49 million

Annual Operating Expenses

$321.16 M
RGNX annual total operating expenses is $321.16 million

Annual Cost Of Goods Sold

$37.21 M
RGNX annual cost of goods sold is $37.21 million

RGNX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.8%0.0%-4298.1%
3 y3 years+38.7%-7.7%-4342.0%
5 y5 years+140.2%+56.6%-6229.0%

RGNX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+11.6%-18.0%+6.2%-192.2%at low
5 y5-yearat high+70.8%-18.0%+34.4%-465.8%at low
alltimeall timeat high+2197.9%-18.0%+1715.1%<-9999.0%at low

REGENXBIO Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.42 M(+3.0%)
$75.65 M(-4.6%)
Jun 2024
-
$18.86 M(+3.1%)
$79.31 M(-5.8%)
Mar 2024
-
$18.29 M(-4.1%)
$84.15 M(-4.9%)
Dec 2023
$88.49 M(+3.8%)
$19.08 M(-17.3%)
$88.49 M(-2.4%)
Sep 2023
-
$23.08 M(-2.6%)
$90.63 M(+2.4%)
Jun 2023
-
$23.70 M(+4.7%)
$88.46 M(+3.3%)
Mar 2023
-
$22.63 M(+6.7%)
$85.60 M(+0.4%)
Dec 2022
$85.28 M(+7.5%)
$21.21 M(+1.4%)
$85.28 M(-1.0%)
Sep 2022
-
$20.92 M(+0.4%)
$86.11 M(-0.1%)
Jun 2022
-
$20.83 M(-6.7%)
$86.22 M(+2.9%)
Mar 2022
-
$22.32 M(+1.3%)
$83.81 M(+5.6%)
Dec 2021
$79.33 M(+24.3%)
$22.04 M(+4.8%)
$79.33 M(+6.0%)
Sep 2021
-
$21.03 M(+14.1%)
$74.86 M(+7.4%)
Jun 2021
-
$18.43 M(+3.3%)
$69.69 M(+4.3%)
Mar 2021
-
$17.84 M(+1.5%)
$66.82 M(+4.7%)
Dec 2020
$63.82 M(+23.2%)
$17.57 M(+10.8%)
$63.82 M(+5.1%)
Sep 2020
-
$15.86 M(+2.0%)
$60.70 M(+6.0%)
Jun 2020
-
$15.55 M(+4.9%)
$57.24 M(+3.9%)
Mar 2020
-
$14.83 M(+2.7%)
$55.09 M(+6.3%)
Dec 2019
$51.81 M
$14.45 M(+16.5%)
$51.81 M(+6.8%)
Sep 2019
-
$12.40 M(-7.5%)
$48.51 M(+7.5%)
DateAnnualQuarterlyTTM
Jun 2019
-
$13.40 M(+16.0%)
$45.12 M(+12.7%)
Mar 2019
-
$11.56 M(+3.7%)
$40.03 M(+8.6%)
Dec 2018
$36.85 M(+35.3%)
$11.14 M(+23.7%)
$36.85 M(+20.8%)
Sep 2018
-
$9.01 M(+8.3%)
$30.51 M(-1.4%)
Jun 2018
-
$8.32 M(-0.7%)
$30.95 M(+6.8%)
Mar 2018
-
$8.38 M(+74.3%)
$28.99 M(+6.5%)
Dec 2017
$27.23 M(+15.4%)
$4.81 M(-49.1%)
$27.23 M(-3.3%)
Sep 2017
-
$9.44 M(+48.6%)
$28.16 M(+13.0%)
Jun 2017
-
$6.36 M(-4.0%)
$24.92 M(+0.8%)
Mar 2017
-
$6.62 M(+15.3%)
$24.73 M(+4.8%)
Dec 2016
$23.59 M(+98.0%)
$5.74 M(-7.4%)
$23.59 M(+6.8%)
Sep 2016
-
$6.20 M(+0.5%)
$22.09 M(+19.7%)
Jun 2016
-
$6.17 M(+12.6%)
$18.46 M(+17.7%)
Mar 2016
-
$5.48 M(+29.2%)
$15.68 M(+31.6%)
Dec 2015
$11.91 M(+209.3%)
$4.24 M(+65.2%)
$11.92 M(+35.5%)
Sep 2015
-
$2.57 M(-24.4%)
$8.80 M(+20.5%)
Jun 2015
-
$3.40 M(+98.0%)
$7.30 M(+87.0%)
Mar 2015
-
$1.72 M(+53.4%)
$3.90 M(+78.4%)
Dec 2014
$3.85 M(-29.6%)
$1.12 M(+4.6%)
$2.19 M(+104.6%)
Sep 2014
-
$1.07 M
$1.07 M
Dec 2013
$5.47 M
-
-

FAQ

  • What is REGENXBIO annual SGA?
  • What is the all time high annual SGA for REGENXBIO?
  • What is REGENXBIO annual SGA year-on-year change?
  • What is REGENXBIO quarterly SGA?
  • What is the all time high quarterly SGA for REGENXBIO?
  • What is REGENXBIO quarterly SGA year-on-year change?
  • What is REGENXBIO TTM SGA?
  • What is the all time high TTM SGA for REGENXBIO?
  • What is REGENXBIO TTM SGA year-on-year change?

What is REGENXBIO annual SGA?

The current annual SGA of RGNX is $88.49 M

What is the all time high annual SGA for REGENXBIO?

REGENXBIO all-time high annual SGA is $88.49 M

What is REGENXBIO annual SGA year-on-year change?

Over the past year, RGNX annual SGA has changed by +$3.21 M (+3.77%)

What is REGENXBIO quarterly SGA?

The current quarterly SGA of RGNX is $19.42 M

What is the all time high quarterly SGA for REGENXBIO?

REGENXBIO all-time high quarterly SGA is $23.70 M

What is REGENXBIO quarterly SGA year-on-year change?

Over the past year, RGNX quarterly SGA has changed by $0.00 (0.00%)

What is REGENXBIO TTM SGA?

The current TTM SGA of RGNX is -$3.18 B

What is the all time high TTM SGA for REGENXBIO?

REGENXBIO all-time high TTM SGA is -$28.81 M

What is REGENXBIO TTM SGA year-on-year change?

Over the past year, RGNX TTM SGA has changed by -$3.25 B (-4298.12%)